News
The Food and Drug Administration has approved Moderna's new COVID-19 vaccine, days after the federal government tightened ...
The FDA has instructed Pfizer and Moderna to add stronger warnings to the labels of their COVID-19 vaccines about the risk of cardiotoxicity in some patients, citing a recent study and new data.
1d
Global News - Inquirer.net on MSNCOVID jabs safe despite US alertA vaccine expert assured Filipinos on Wednesday that all vaccines are safe after the United States Food and Drug ...
Discover how the new COVID-19 variant NB. 1. 8. 1 is causing global concern as it spreads from China to the U. S. , prompting ...
Discover how the new COVID-19 variant NB. 1. 8. 1 is causing global concern as it spreads from China to the U. S. , prompting ...
Discover the rise of the new COVID-19 variant NB. 1. 8. 1, its implications for global health, and the current vaccine ...
Although it appears not to cause more severe illness, preliminary data demonstrate that the variant exhibits significant ...
Pfizer's innovative business should grow faster after it divests its off-patent division Upjohn in 2020 to create Viatris and ...
The Pfizer/BioNTech bivalent COVID-19 vaccine (Original and Omicron BA.4/BA.5) has the FDA’s EUA for use in individuals 5 years and over as a single booster dose administered at least two months ...
Moderna’s newest lower-dose COVID-19 vaccine is approved for all adults 65 and older, and for people aged 12 to 64 who are at ...
Biopharma financings totaled $21.38 billion through May 2025, down sharply from $62.57 billion during the same period in 2024, but roughly in line with levels seen in 2023 and 2022. Biopharma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results